Literature DB >> 8404951

A method for stabilising technetium-99m exametazime prepared from a commercial kit.

P S Weisner1, G R Bower, L A Dollimore, A M Forster, B Higley, A E Storey.   

Abstract

Technetium-99m exametazime (99mTc-d,l-HMPAO), prepared by the reconstitution of the Ceretec kit, is widely used in the investigation of regional cerebral blood flow. The radiochemical purity specification of not less than 80% lipophilic complex requires that the kit is used within 30 min of reconstitution. In certain circumstances this imposes restrictions on its clinical availability. A number of approaches to extending the 30-min shelf life have been proposed and these are discussed. A method of stabilising the kit by the addition of 200 micrograms cobalt chloride hexahydrate (CoCl2 x 6H2O) in 2 ml of water is described. The addition of this solution can extend the shelf life of the reconstituted kit to at least 5 h post reconstitution.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8404951     DOI: 10.1007/bf00181755

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  5 in total

1.  Stabilization of [99mTc]HMPAO--1. Ethanolic preparation.

Authors:  M W Billinghurst; D N Abrams; M S Lawson
Journal:  Int J Rad Appl Instrum A       Date:  1991

2.  Use of sodium iodide to overcome the eluate age restriction for Ceretec reconstitution.

Authors:  V J Bayne; A M Forster; D A Tyrrell
Journal:  Nucl Med Commun       Date:  1989-01       Impact factor: 1.690

3.  Radical scavengers and the stability of 99mTc-radiopharmaceuticals.

Authors:  R Berger
Journal:  Int J Appl Radiat Isot       Date:  1982-12

4.  Kinetic analysis of technetium-99m d,1-HM-PAO decomposition in aqueous media.

Authors:  J C Hung; M Corlija; W A Volkert; R A Holmes
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

5.  A routine method for using sodium iodide to stabilize sodium pertechnetate [99Tcm] dispensed for the preparation of 99Tcm-exametazime.

Authors:  A M Millar
Journal:  Nucl Med Commun       Date:  1992-05       Impact factor: 1.690

  5 in total
  5 in total

1.  Localization of epileptic foci by single-photon emission tomography with new radiotracers.

Authors:  J T Kuikka; S F Berkovic
Journal:  Eur J Nucl Med       Date:  1994-11

2.  Evaluation of technetium-99m exametazime stabilised with cobalt chloride as a blood flow tracer in focal cerebral ischaemia.

Authors:  G Gartshore; P Bannan; J Patterson; B Higley; J McCulloch
Journal:  Eur J Nucl Med       Date:  1994-09

3.  Formulation of a single-component kit for the preparation of technetium-99m labelled ethyl cysteinate dimer: biological and clinical evaluation.

Authors:  A Afshan; M Jehangir; M Ashraf; A Waqar; E Chiotellis
Journal:  Eur J Nucl Med       Date:  1994-09

4.  Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour.

Authors:  K O Mang'era; H P Vanbilloen; C W Schiepers; A M Verbruggen
Journal:  Eur J Nucl Med       Date:  1995-10

5.  A standardized method for the construction of tracer specific PET and SPECT rat brain templates: validation and implementation of a toolbox.

Authors:  David Vállez Garcia; Cindy Casteels; Adam J Schwarz; Rudi A J O Dierckx; Michel Koole; Janine Doorduin
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.